31 AUG 2009
We proudly invite you to our first Symposium on Scale Up of Oral Solid Dosage Forms, which is organised in joint partnership of GEA Pharma Systems and Evonik Industries. The participants benefit from the combination of expert know how of GEA and Evonik scientists as well as experts from the pharmaceutical industry. Where as GEA is focused on particle-, process engineering and equipment, Evonik contributes with more than 50 years of experience in EUDRAGIT® processing and formulation. The program is rounded out with external guest speakers for the latest directions in Quality by Design (QbD) and Process Analytical Technology (PAT).
Target Group:
Managers and Senior Scientists being responsible for process development, scale up or production who want to increase their knowledge in process characterization and scale up on the main technologies for oral solid dosage forms production.
Program Highlights:
-
Challenges in Scale Up
-
Physico-Chemical Characteristics & Processing of EUDRAGIT®
-
Fluid Bed Processes – Particle Coating & Drying
-
How PAT Supports Scale Up
-
Industrial Case Study – Fluid Bed Pellet Coating
-
Design Space as Success Factor for Scale Up
-
Demonstrations in Groups at GEA Laboratories
-
Case Studies in GEA Equipment
-
Expert Discussions
Speakers:
- Andrew Birkmire - GEA Pharma Systems, USA
- Dr. Xiaoming Li - Eli Lilly and Company, USA
- Dr. Christian Meier - Evonik Röhm GmbH, Germany
- Dr. Brigitte Skalsky - Evonik Röhm GmbH, Germany
- Dr. Harald Stahl - GEA Pharma Systems, Germany
- Dr. Iris Ziegler - Nycomed GmbH, Germany
Programme details and registration form.